CAS 96604-21-6 Ocinaplon;Ocinaplonsustainedrelease, Sole GMP Manufacturer

Ocinaplon;Ocinaplonsustainedrelease, CAS 96604-21-6  Sole GMP Manufacturer

Ocinaplon;Ocinaplonsustainedrelease, CAS 96604-21-6  stable novel crystalline or amorphous form both we have, Ocinaplon;Ocinaplonsustainedrelease, CAS 96604-21-6 no any IP problem. Ocinaplon;Ocinaplonsustainedrelease, CAS 96604-21-6  DMF filling, free sample of Ocinaplon;Ocinaplonsustainedrelease, CAS 96604-21-6 .

EOS Med Chem have already carried out Ocinaplon;Ocinaplonsustainedrelease, CAS 96604-21-6  batch production, also have completed the development of quality standards and process validation. The stable process is the guarantee of product quality. For Ocinaplon;Ocinaplonsustainedrelease, CAS 96604-21-6  , we use HPLC-UV detection instead of other companies' HPLC-ELSD test, Our detection method is more sensitive.

Below is Ocinaplon;Ocinaplonsustainedrelease, CAS 96604-21-6  Intermeidates list, most from GMP plant:

Ocinaplon;Ocinaplonsustainedrelease, CAS 96604-21-6 Intermediate,  7459-35-0, stock 4.2kg, assay 98.7%, White powder.

Ocinaplon;Ocinaplonsustainedrelease, CAS 96604-21-6 Intermediate,  69-74-9, stock 3.4kg, assay 98.2%, White powder.

Ocinaplon;Ocinaplonsustainedrelease, CAS 96604-21-6  HNMR, MASS, COA, MSDS we have.

Ocinaplon;Ocinaplonsustainedrelease, CAS 96604-21-6 , free sample, welcome to ask:

2019 CHINA CPHI  E2A62
2019 WORLD CPHI 101C45
FDA 2015-2018 New API and Intermediates, Clinical Phase II, III Intermediates, GMP Custom synthesis, DMF filling, I am big.

R&D Center: 8000 sq, More than 100 hoods
Pilot Plant: 20000sq, 40 reactors from 5-200L
Manufacturing Site: 800000sq, 40 reactors from 100-5000L
Web: www.eosmedchem.com
Email: info@eosmedchem.com; eosmedchem@gmail.com